Dr. Pelton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Mary Washington Medical Plaza
1101 Sam Perry Blvd, Suite 321
Fredericksburg, VA 22401Phone+1 540-741-4960Fax+1 540-741-4967
Summary
- Dr. Jeffrey Pelton is a surgical oncologist in Fredericksburg, VA and is affiliated with Mary Washington Hospital and the Mary Washington Health Care system. He received his medical degree from Uniformed Services University of the Health Sciences and has been in practice 33 years. He specializes in General Surgery, Hepatobiliary Surgery, Pancreas, Surgical Oncology (including breast cancer) and is also experienced with treating Esophageal cancer, Gastric cancer, thyroid cancer, melanoma, and soft tissue sarcomas.
Education & Training
- Johns Hopkins UniversityMS, Biotechnology, 2010 - 2012
- Johns Hopkins University Carey School of BusinessMBA, Health Care Business Administration, 2007 - 2010
- Wilford Hall USAF Medical Center1988 - 1999
- Temple University Hospital/Fox Chase Cancer CenterFellowship, Complex General Surgical Oncology, 1989 - 1991
- San Antonio Uniformed Services Health Education ConsortiumResidency, Surgery, 1984 - 1989
- Wilford Hall USAF Medical Center1985 - 1988
- Wilford Hall USAF Medical Center1984 - 1985
- UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1984
- UCLABA, Microbiology & Immunology, 1975 - 1980
Certifications & Licensure
- CA State Medical License 1999 - Present
- VA State Medical License 2005 - 2026
- MD State Medical License 1987 - 2025
- TX State Medical License 2019 - 2025
- DC State Medical License 2005 - 2024
- PA State Medical License 1989 - 2002
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Surgeon General’s Award First Place, Resident/Fellow Paper Competition, Society of Air Force Clinical Surgeons, San Antonio, Texas, 1991
- Surgeon General’s Award Third Place, Resident/Fellow Paper Competition, Society of Air Force Clinical Surgeons Washington D.C, 1990
- Finalist, Resident/Fellow Paper Competition Society of Surgical Oncology Annual Meeting, Washington, DC, 1990
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsLymphokine-Activated Killer Cell Suppressor Factor in Malignant EffusionsJeffrey J. Pelton, Douglas D. Taylor, Wyatt C. Fowler, Cicek Gercel Taylor, Ned Z. Carp
Archives of Surgery. 1991-04-01 - 8 citationsRenal vein leiomyosarcoma.Jeffrey J. Pelton, Juan P. Palazzo, Robert O. Peterson, Burton L. Eisenberg
Journal of Surgical Oncology. 1990-10-01 - 30 citationsComparison of liver function tests after hepatic lobectomy and hepatic wedge resectionJ J Pelton, John P. Hoffman, Burton L. Eisenberg
The American Surgeon. 1998-05-01
Journal Articles
- Middle Colic Artery Originating from the Gastroduodenal Artery Discovered During a Whipple Operation.Kwong, Mei Li, Pelton JJ, Journal of Surgical Case Reports, 1/2019
- Comparison of Liver Function Tests Following Hepatic Lobectomy and Hepatic Wedge ResectionPelton, J.J., Hoffman, J.P., Eisenberg, B.L., Am Surgeon
- A Technique of Bronchoscopic Intubation.Pelton, J.J., Ratner, I.A. Management of the Obstructed Airway due to Tumor, Ann Thorac Surg. 1988;48:301-302
- Join now to see all
Books/Book Chapters
Lectures
- The Limits of Hemodilution after Resuscitation from Hemorrhagic Shock.Surgical Forum, Critical Care, Atlanta GA
- The Limits of Hemodilution after Resuscitation from Hemorrhagic Shock.American College of Surgeons South Texas Regional Meeting, Temple TX
- Tumor Modulation of rIL-2 - Activated Killer (LAK) Cells.Immunity to Cancer 1989 Society of Biologic Therapy, Annual Meeting (Poster Session), Williamsburg
- Join now to see all
Press Mentions
- HEALTH BRIEFS: July 7, 2019July 7th, 2019
- Total Synthesis of Altemicidin: A Surprise Ending for a Monoterpene AlkaloidNovember 1st, 2023
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: